TD Cowen on TransMedics Amid 6% Gain: 'transplant logistics business experienced ~18.5% y/y growth'

July 1, 2026 10:34 AM

TD Cowen analyst Joshua Jennings reiterated a Buy rating and $120.00 price target on TransMedics Group (NASDAQ: TMDX), according to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found